P552: Measurable Residual Disease Detected By Wt1 Is An Independent Predictor Of Survival In Children With Acute Myeloid Leukemia

Mariam Elsherif,Sonia Ahmed,Dina Yassin,Nahla Elsharkawy,Ayman S Mohamed,Nouran Yasser,Hanafy Hafez,Alaa Elhaddad

DOI: https://doi.org/10.1097/01.hs9.0000969116.12080.90

2023-08-11

HemaSphere

Abstract:Background: Molecular testing has an evolving role in monitoring of measurable residual disease (MRD) to refine risk stratification and to guide treatment strategies in pediatric patients with AML. Wilms tumor gene 1 ( WT1 ) is frequently overexpressed in AML and has been proposed as a potential molecular marker for MRD.

English Else